Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atracurium dose comparison for laryngeal mask airway insertion during cataract surgery
IRCT20180416039326N5Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of atracurium in cataract (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Time of insertion of laryngeal mask airway. Started Aug 2017; status: completed.
02
Drugs
atracurium
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20180416039326N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N5.